|
🐜
|
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network
37 auth.
O. Hermine,
E. Hoster,
J. Walewski,
A. Bosly,
S. Stilgenbauer,
C. Thieblemont,
M. Szymczyk,
R. Bouabdallah,
M. Kneba,
M. Hallek,
G. Salles,
P. Feugier,
V. Ribrag,
J. Birkmann,
R. Forstpointner,
...
C. Haioun,
M. Hänel,
R. Casasnovas,
J. Finke,
N. Peter,
K. Bouabdallah,
C. Sebban,
T. Fischer,
U. Dührsen,
B. Metzner,
G. Maschmeyer,
L. Kanz,
C. Schmidt,
R. Delarue,
N. Brousse,
W. Klapper,
E. Macintyre,
M. Delfau-Larue,
C. Pott,
W. Hiddemann,
M. Unterhalt,
M. Dreyling
|
8 |
2016 |
8
🐜
|
|
🐜
|
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
29 auth.
U. Kaiser,
Irmgard Uebelacker,
U. Abel,
J. Birkmann,
L. Trümper,
H. Schmalenberg,
T. Karakas,
B. Metzner,
D. Hossfeld,
H. Bischoff,
A. Franke,
M. Reiser,
P. Müller,
L. Mantovani,
M. Grundeis,
...
F. Rothmann,
C. von Seydewitz,
R. Mesters,
E. Steinhauer,
D. Krahl,
K. Schumacher,
M. Kneba,
M. Baudis,
N. Schmitz,
R. Pfab,
H. Köppler,
R. Parwaresch,
M. Pfreundschuh,
K. Havemann
|
7 |
2002 |
7
🐜
|
|
🐜
|
Prospective trial on topotecan salvage therapy in primary CNS lymphoma.
7 auth.
L. Fischer,
E. Thiel,
H. Klasen,
J. Birkmann,
K. Jahnke,
P. Martus,
...
A. Korfel
|
7 |
2006 |
7
🐜
|
|
🐜
|
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
7 auth.
M. Wilhelm,
M. Smetak,
K. Schaefer-Eckart,
B. Kimmel,
J. Birkmann,
H. Einsele,
...
V. Kunzmann
|
6 |
2014 |
6
🐜
|
|
🐜
|
Tumor-promoting Versus Tumor-antagonizing Roles of &ggr;&dgr; T Cells in Cancer Immunotherapy: Results From a Prospective Phase I/II Trial
10 auth.
V. Kunzmann,
M. Smetak,
B. Kimmel,
K. Weigang-Koehler,
M. Goebeler,
J. Birkmann,
...
J. Becker,
I. Schmidt-Wolf,
H. Einsele,
M. Wilhelm
|
6 |
2012 |
6
🐜
|
|
🐜
|
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas
17 auth.
A. Korfel,
T. Elter,
E. Thiel,
M. Hänel,
R. Möhle,
R. Schroers,
M. Reiser,
M. Dreyling,
J. Eucker,
C. Scholz,
...
B. Metzner,
A. Röth,
J. Birkmann,
U. Schlegel,
P. Martus,
G. Illerhaus,
L. Fischer
|
6 |
2013 |
6
🐜
|
|
🐜
|
Complete spontaneous remission in a patient with metastatic non-small-cell lung cancer. Case report, review of the literature, and discussion of possible biological pathways involved.
8 auth.
H. Kappauf,
W. Gallmeier,
P. Wünsch,
H. Mittelmeier,
J. Birkmann,
G. Büschel,
...
G. Kaiser,
J. Kraus
|
6 |
1997 |
6
🐜
|
|
🐢
|
First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation
10 auth.
M. Wilhelm,
M. Smetak,
P. Reimer,
E. Geissinger,
T. Ruediger,
B. Metzner,
...
N. Schmitz,
A. Engert,
K. Schaefer-Eckart,
J. Birkmann
|
5 |
2016 |
5
🐢
|
|
🐬
|
PD-1 signaling modulates interferon-γ production by Gamma Delta (γδ) T-Cells in response to leukemia
T. Hoeres,
Elisabeth Holzmann,
M. Smetak,
J. Birkmann,
M. Wilhelm
|
5 |
2018 |
5
🐬
|
|
🐜
|
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial.
20 auth.
A. Korfel,
M. Weller,
P. Martus,
P. Roth,
H. Klasen,
A. Roeth,
M. Rauch,
B. Hertenstein,
T. Fischer,
T. Hundsberger,
...
M. Leithäuser,
T. Birnbaum,
H. Kirchen,
H. Mergenthaler,
J. Schubert,
Wolfgang E. Berdel,
J. Birkmann,
M. Hummel,
E. Thiel,
L. Fischer
|
5 |
2012 |
5
🐜
|
